Colgate Palmolive Co (CL) stock price, news and key stats

Price

Last close as of Sep 16, 2026. Delayed data; not a live quote.

Previous close

$87.00

Open

$87.10

Day range

$86.68 – $87.76

Volume

5.9M

About Colgate Palmolive Co

Latest CL news

• Pet owners at risk of being ripped off by private equity firms as vet ownership rules change
  Guardian Business · Aug 30, 2026

  Recent changes to veterinary ownership regulations by the Competition and Markets Authority (CMA) have raised concerns among pet owners regarding potential exploitation by private equity firms. The new rules may enable multinational corporations to obscure their ownership of veterinary practices, leading to a lack of transparency in pricing and service quality. This shift comes at a time when the cost of small animal veterinary services has surged by 63% from 2016 to 2023, prompting fears that pet owners could face even higher bills as profit-driven entities gain more control over veterinary care. Critics argue that the influx of private equity into the veterinary sector could prioritize financial returns over animal welfare, potentially compromising the quality of care. With the veterinary market already experiencing significant price increases, the lack of clear ownership structures may further diminish accountability and competition. As pet owners navigate this evolving landscape, they may find themselves at the mercy of rising costs and diminished service standards, raising questions about the long-term implications for pet health and owner trust. Market analysts suggest that these changes could lead to increased consolidation in the veterinary industry, as larger firms seek to acquire smaller practices. This consolidation may reduce competition, ultimately resulting in higher prices for consumers. As the veterinary landscape transforms, stakeholders will need to monitor how these ownership changes affect service delivery and pricing, ensuring that pet owners are not left vulnerable to exploitation in a market increasingly influenced by private equity interests.

• Consumer products M&A update: Recovery pauses amid renewed uncertainty
  IPO & M&A · Aug 27, 2026

  The consumer products mergers and acquisitions (M&A) landscape has hit a pause in its recovery, as renewed economic uncertainty casts a shadow over potential deals. After a period of robust activity fueled by post-pandemic optimism, recent market dynamics—including inflationary pressures, rising interest rates, and geopolitical tensions—have contributed to a more cautious approach among buyers and sellers. According to industry analysts, this hesitance may lead to a slowdown in deal-making, as companies reassess their valuations and strategic priorities in light of shifting consumer behaviors. Market implications of this slowdown are significant. With many consumer goods companies facing squeezed margins due to increased production costs, the appetite for acquisitions may diminish further. Investors are likely to adopt a wait-and-see strategy, prioritizing stability over aggressive expansion. Additionally, companies that had previously planned to divest non-core assets may reconsider, opting instead to focus on strengthening their existing portfolios. As uncertainty persists, the M&A landscape in the consumer products sector may remain subdued, impacting overall market confidence and valuations in the near term.

Index membership

• S&P 500 · Consumer Staples

Related Consumer Staples stocks

• ADMArcher Daniels Midland
• BF-BBrown–Forman
• BGBunge Global
• CASYCasey's
• CHDChurch & Dwight
• CLXClorox
• COSTCostco
• DGDollar General